The opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035.

 

Treg based therapies have become a research hotspot in the field of immunotherapy due to their ability to prevent / delay graft rejection and control autoimmune responses generated post adoptive transfer in vivo

 

Roots Analysis has announced the addition of “Regulatory T-Cell (Tregs) Therapies Market, 2021 – 2035” report to its list of offerings.

 

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of drug developers engaged in the development of regulatory T-cell therapies. 

§  A detailed analysis of more than 180+ completed, ongoing and planned clinical studies of regulatory T-cell therapies.

§  Detailed profiles of developers of regulatory T-cell therapies (shortlisted on the basis of the number of pipeline products).

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  A detailed analysis of various investments undertaken by companies in this domain.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 

§  Type of Product

  • Tregs
  • Interleukins
  • Small molecules

 

§  Target Indication

  • Crohn’s Disease
  • Bipolar Disorder
  • Allergic Rhinoconjunctivitis
  • COVID 19
  • Diabetes Mellitus
  • Systemic Lupus Erythematosus
  • Alzheimer’s Disease
  • Graft Vs Host Disease

 

§  Key Geographical Regions 

  • North America
  • Europe
  • Asia Pacific

 

Key companies covered in the https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html

 

§  Abata Therapeutics

§  Cellenkos

§  Coya Therapeutics

§  ILTOO Pharma

§  NEKTAR

§  Roche

§  Sonoma Biotherapeutics

§  TeraImmune

§  TRACT Therapeutics

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html or email sales@rootsanalysis.com

 

Other Recent Offerings

1.     CD47 Targeting Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030

2.      Antibody Drug Conjugates  Market (6th Edition): Industry Trends and Global Forecasts, 2021-2030

3.      Novel T-Cell Immunotherapies  Market: Industry Trends and Global Forecasts, 2021-2030

4.      TIL-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030

5.      Peptide Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030

6.      CRISPR Based Therapeutics Market: Focus on Cartridges, Syringes and Vials

7.      (2nd Edition), 2021-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Comments

Post a Comment

Popular posts from this blog

The RNA targeting small molecules therapeutics market is estimated to be worth USD 8.3 billion in 2030.

  In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting, to treat a wide range of clinical conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, “ RNA Targeting Small Molecules Therapeutics Market ”   The report features an extensive study of the current market landscape and future potential of the players engaged in the discovery and development of RNA targeting small molecules therapeutics. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:   §   An in-depth review of the market landscape of players that are engaged in the discovery and development of RNA targeting small molecules therapeutics being evaluated at both preclinical and clinical stag...
Read more

Site management organizations (SMO) market is projected to grow at an annualized rate of ~10% during the period 2021-2035.

  In addition to being a time and cost intensive process, clinical trials are fraught with several challenges; considering the expertise available with site management organizations ( SMO s) to conduct such studies in an efficient manner, trial sponsors are actively outsourcing their requirements   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Site Management Organizations (SMO) Market, 2021–2035 .”   The study features an in-depth analysis, highlighting the capabilities of clinical trial site management service providers engaged in this domain. Amongst other elements, the report features: §   A detailed assessment of the current market landscape of companies offering clinical trial site management services.  §   A competitiveness analysis of various service providers segregated into three peer groups based on location of their headquarters (North America, Europe, and Asia-Pacific and RoW). The companies ...
Read more